Labetalol Hydrochloride Structural Formula (0ddb0de2 08a1 4d9e 960d 88425cfa564d 01)
Labetalol Hydrochloride
Product Images NDC 68258-6047
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 68258-6047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 68258-6047-xx (Ndc 68258 6047 Xx Teva)
This is a product description of the medicine Labetalol HCI 200 mg manufactured for Teva Pharmaceuticals in Sellersville, PA. The tablets are white, round, and film-coated, with 4365/Teva debossed on them. The product is dispensed in a tight/light-resistant container and each tablet contains 200 mg of Labetalol Hydrochloride USP. The medicine is taken orally as directed, twice a day and may cause dizziness, nausea, or fatigue. The lot number and expiry date are mentioned but illegible, and the Pedigree number is 20587877. The product is for prescription-only, and the package should be stored at 68°-77° F. Children should not have access to the medicine. The rest of the text mentions the NDC number and Rx number for the product but has repeated information that does not add any new information. The product is exclusively packaged by Dispensing Solution in Santa Ana, CA 92704.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
